Bhatt Padmanabh P. (CIK 1539215) reported 40 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-18). Recent activity: Buy SUPN (22,750 shares), Sell SUPN (412 shares), Buy SUPN (18,000 shares), Buy SUPN (5,000 shares), Sell SUPN (34,114 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-18 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sr. VP of IP, CSO | Buy | 22,750 | $836,062 |
| 2026-03-18 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sr. VP of IP, CSO | Sell | 412 | $20,798 |
| 2026-03-18 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sr. VP of IP, CSO | Buy | 18,000 | $579,600 |
| 2026-03-18 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sr. VP of IP, CSO | Buy | 5,000 | $139,700 |
| 2026-03-18 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sr. VP of IP, CSO | Sell | 34,114 | $1.7M |
| 2026-03-18 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sr. VP of IP, CSO | Sell | 15,886 | $802,084 |
| 2026-03-18 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sr. VP of IP, CSO | Buy | 22,750 | $896,350 |
| 2026-03-18 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sr. VP of IP, CSO | Buy | 4,250 | $125,842 |
| 2026-03-18 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sr. VP of IP, CSO | Buy | 15,000 | $579,000 |
| 2026-03-18 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sr. VP of IP, CSO | Sell | 27,710 | $1.4M |
| 2026-03-18 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sr. VP of IP, CSO | Sell | 22,290 | $1.1M |
| 2026-03-18 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sr. VP of IP, CSO | Buy | 7,250 | $285,650 |
| 2026-03-18 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sr. VP of IP, CSO | Sell | 6,838 | $338,823 |
| 2026-03-18 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sr. VP of IP, CSO | Buy | 12,250 | $450,188 |
| 2026-02-26 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sr. VP of IP, CSO | Buy | 1,250 | $0 |
| 2026-02-26 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sr. VP of IP, CSO | Sell | 650 | $32,948 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sr. VP of IP, CSO | Buy | 1,125 | $0 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sr. VP of IP, CSO | Sell | 581 | $29,834 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sr. VP of IP, CSO | Buy | 750 | $0 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sr. VP of IP, CSO | Buy | 1,250 | $0 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sr. VP of IP, CSO | Sell | 646 | $32,856 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sr. VP of IP, CSO | Sell | 354 | $18,004 |
| 2025-12-19 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sr. VP of IP, CSO | Buy | 1,500 | $0 |
| 2025-12-19 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sr. VP of IP, CSO | Sell | 710 | $31,552 |
| 2025-08-27 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sr. VP of IP, CSO | Buy | 1,250 | $0 |
Source: SEC Form 4 filings · as of 2026-03-18